New Research: Key Drivers of Growth for Coty, Bristol-Myers Squibb, Carnival, Agenus, Steel Dynamics, and Impax Labs - A Look Behind the Scenes at Consolidated Results, Factors of Influence, Major Initiatives and Sustained Production

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Coty Inc. (NYSE:COTY), Bristol-Myers Squibb Company (NYSE:BMY), Carnival Corporation (NYSE:CCL), Agenus Inc. (NASDAQ:AGEN), Steel Dynamics, Inc. (NASDAQ:STLD), and Impax Laboratories, Inc. (NASDAQ:IPXL) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

COTY DOWNLOAD: http://Fundamental-Markets.com/register/?so=COTY

BMY DOWNLOAD: http://Fundamental-Markets.com/register/?so=BMY

CCL DOWNLOAD: http://Fundamental-Markets.com/register/?so=CCL

AGEN DOWNLOAD: http://Fundamental-Markets.com/register/?so=AGEN

STLD DOWNLOAD: http://Fundamental-Markets.com/register/?so=STLD

IPXL DOWNLOAD: http://Fundamental-Markets.com/register/?so=IPXL

 (You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine  Coty Inc. (NYSE:COTY), Bristol-Myers Squibb Company (NYSE:BMY), Carnival Corporation (NYSE:CCL), Agenus Inc. (NASDAQ:AGEN), Steel Dynamics, Inc. (NASDAQ:STLD), and Impax Laboratories, Inc. (NASDAQ:IPXL) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today’s readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 6, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (except per share amounts).

-----------------------------------------

COTY INC. (COTY) REPORT OVERVIEW

Coty's Recent Financial Performance

For the three months ended March 31, 2017 vs March 31, 2016, Coty reported revenue of $2,032.1 vs $950.7 (up 113.7%), diluted earnings per share -$0.22 vs -$0.08. For the twelve months ended June 30, 2017 vs June 30, 2016, Coty reported revenue of $7,650.3 vs $4,349.1 (up 75.9%), diluted earnings per share -$0.66 vs $0.44. Coty is expected to report earnings on 11/09/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 9 analysts' forecasts, the consensus EPS forecast for the quarter is $0.07. The reported EPS for the same quarter last year was $0.23.

To read the full Coty Inc. (COTY) report, download it here: http://Fundamental-Markets.com/register/?so=COTY

-----------------------------------------

BRISTOL-MYERS SQUIBB COMPANY (BMY) REPORT OVERVIEW

Bristol-Myers Squibb's Recent Financial Performance

For the three months ended September 30, 2017 vs September 30, 2016, Bristol-Myers Squibb reported revenue of $5,254 vs $4,922 (up 6.7%), diluted earnings per share $0.51 vs $0.72 (down 29.2%), and dividends per share $0.39 vs $0.38 (up 2.6%). For the twelve months ended December 31, 2016 vs December 31, 2015, Bristol-Myers Squibb reported revenue of $19,427 vs $16,560 (up 17.3%), diluted earnings per share $2.65 vs $0.93 (up 184.9%), and dividends per share $1.53 vs $1.49 (up 2.7%).

To read the full Bristol-Myers Squibb Company (BMY) report, download it here: http://Fundamental-Markets.com/register/?so=BMY

-----------------------------------------

CARNIVAL CORPORATION (CCL) REPORT OVERVIEW

Carnival's Recent Financial Performance

For the three months ended August 31, 2017 vs August 31, 2016, Carnival reported revenue of $5,515 vs $5,097 (up 8.2%), diluted earnings per share $1.83 vs $1.93 (down 5.2%), and dividends per share $0.40 vs $0.35 (up 14.3%). For the twelve months ended November 30, 2016 vs November 30, 2015, Carnival reported revenue of $16,389 vs $15,714 (up 4.3%), diluted earnings per share $3.72 vs $2.26 (up 64.6%), and dividends per share $1.35 vs $1.10 (up 22.7%). Carnival is expected to report earnings on 12/19/2017. The report will be for the fiscal Quarter ending November 2017. According to Zacks Investment Research, based on 8 analysts' forecasts, the consensus EPS forecast for the quarter is $0.51. The reported EPS for the same quarter last year was $0.67.

To read the full Carnival Corporation (CCL) report, download it here: http://Fundamental-Markets.com/register/?so=CCL

-----------------------------------------

AGENUS INC. (AGEN) REPORT OVERVIEW

Agenus's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Agenus reported revenue of $4.2 vs $6.6 (down 36.4%), diluted earnings per share -$0.32 vs -$0.33. For the twelve months ended December 31, 2016 vs December 31, 2015, Agenus reported revenue of $22.6 vs $24.8 (down 8.9%), diluted earnings per share -$1.46 vs -$1.13. Agenus is expected to report earnings on 11/07/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is -$0.37. The reported EPS for the same quarter last year was -$0.47.

To read the full Agenus Inc. (AGEN) report, download it here: http://Fundamental-Markets.com/register/?so=AGEN

-----------------------------------------

STEEL DYNAMICS, INC. (STLD) REPORT OVERVIEW

Steel Dynamics's Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Steel Dynamics reported revenue of $2,390.7 vs $2,023.9 (up 18.1%), diluted earnings per share $0.63 vs $0.58 (up 8.6%), and dividends per share $0.155 vs $0.140 (up 10.7%). For the twelve months ended December 31, 2016 vs December 31, 2015, Steel Dynamics reported revenue of $7,777.1 vs $7,594.4 (up 2.4%), diluted earnings per share $1.56 vs -$0.54, and dividends per share $0.56 vs $0.55 (up 1.8%).

To read the full Steel Dynamics, Inc. (STLD) report, download it here: http://Fundamental-Markets.com/register/?so=STLD

-----------------------------------------

IMPAX LABORATORIES, INC. (IPXL) REPORT OVERVIEW

Impax Labs' Recent Financial Performance

For the three months ended June 30, 2017 vs June 30, 2016, Impax Labs reported revenue of $202.1 vs $172.6 (up 17.1%), diluted earnings per share -$0.28 vs -$0.04. For the twelve months ended December 31, 2016 vs December 31, 2015, Impax Labs reported revenue of $824.4 vs $860.5 (down 4.2%), diluted earnings per share -$6.63 vs $0.54. Impax Labs is expected to report earnings on 11/09/2017. The report will be for the fiscal Quarter ending September 2017. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $0.19. The reported EPS for the same quarter last year was $0.37.

To read the full Impax Laboratories, Inc. (IPXL) report, download it here: http://Fundamental-Markets.com/register/?so=IPXL

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world’s leading brokerages for over a decade—and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets’ roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets’ oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets’ roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets’ Compliance department by Phone, at +1 667-401-0010, or by E-mail at [email protected].

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: [email protected]

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at [email protected].

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.